Showing results (361-370 of 561) with videos related to

Sort By:
Pageof 57
Prostate Cancer and Prostatic Diseases|July 6, 2021
A transcriptomic model for homologous recombination deficiency in prostate cancerAdam B Weiner, Yang Liu, Matthew McFarlane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2016
Suramin inhibits cullin-RING E3 ubiquitin ligasesKenneth Wu, Robert A Chong, Qing Yu, et al.
Nature|November 4, 2005
Crustal rheology of the Himalaya and Southern Tibet inferred from magnetotelluric dataM J Unsworth, A G Jones, W Wei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitinationRobert A Chong, Kenneth Wu, Donald E Spratt, et al.
JAMA Network Open|October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical TrialSoumyajit Roy, Shawn Malone, Kevin Wing, et al.
Cancer|January 7, 2020
Genomic and clinical characterization of stromal infiltration markers in prostate cancerBrandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Pageof 57